Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis

Yu Lu,Aoxi Cui,Xiaobo Zhang
DOI: https://doi.org/10.1080/19490976.2024.2348441
IF: 12.2
2024-05-07
Gut Microbes
Abstract:Colorectal cancer (CRC), a malignant tumor worldwide, is associated with gut microbiota. The influence of gut microbe-derived metabolites on CRC has attracted a lot of attention. However, the role of immunity mediated by commensal microbiota-derived metabolites in tumorigenesis of CRC is not intensively explored. Here we monitored the gut microbial dysbiosis in CRC mouse model ( Apc Min/+ model) without dietary and pharmacological intervention, followed by characterized of metabolites enriched in CRC model mice. Profound changes of gut microbiome (bacteriome) were observed during intestinal disorders. Metabolomic profiling indicated that agmatine, derived from the gut bacteria i.e. Blautia, Odoribacter, Alistipes and Paraprevotella , could interact with Rnf128 to suppress the Rnf128-mediated ubiquitination of β-catenin to further upregulate the downstream targets of β-catenin including Cyclin D1, Lgr5, CD44 and C-myc, thus activating Wnt signaling. The activated Wnt signaling pathway promoted dysplasia of intestinal cells and inflammatory infiltration of lymphocytes via inducing the upregulation of pro-inflammatory cytokines (IL-6 and TNF-α) and downregulation of anti-inflammatory cytokine (IL-10), thereby contributing to colorectal carcinogenesis. Therefore, our study presented novel insights into the roles and mechanisms of gut microbiota in pathogenesis of CRC.
gastroenterology & hepatology,microbiology
What problem does this paper attempt to address?
The paper aims to explore the role of the symbiotic microbial metabolite agmatine in the pathogenesis of colorectal cancer (CRC) and its specific mechanisms. The study constructed a mouse model of colorectal cancer (ApcMin/+ model), monitored changes in the gut microbiota of the mice, and identified metabolites associated with colorectal cancer. The research found that agmatine, produced by gut bacteria such as Blautia, Odoribacter, Alistipes, and Paraprevotella, can interact with Rnf128, inhibiting Rnf128-mediated β-catenin ubiquitination, thereby activating the Wnt signaling pathway. This process further upregulated the expression of β-catenin downstream targets (such as Cyclin D1, Lgr5, CD44, and C-myc), leading to abnormal proliferation and inflammatory infiltration of intestinal cells, ultimately promoting the occurrence of colorectal cancer. Therefore, this study reveals new insights into the role of gut microbiota and their metabolites in the pathogenesis of colorectal cancer.